SCHEMBL14536736

SCHEMBL14536736

Cc1nc(C2CC(CO)C2)n2ccnc(N)c12

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 17/20 0.59
IGF1R P08069 4/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19264256 0.90 TNK2 (0.59) TNK2IGF1R
SCHEMBL4541532 0.86 TNK2 (0.58) TNK2IGF1RCYP3A4
SCHEMBL401216 0.86 TNK2 (0.58) TNK2IGF1RCYP3A4
SCHEMBL10226172 0.86 TNK2 (0.58) TNK2IGF1RCYP3A4
SCHEMBL19264081 0.85 TNK2 (0.57) TNK2IGF1R
SCHEMBL19264180 0.84 TNK2 (0.46) TNK2IGF1RCYP3A4
SCHEMBL2797385 0.80 TNK2 (0.52) TNK2IGF1R
SCHEMBL14536941 0.79 TNK2 (0.59) TNK2IGF1R
SCHEMBL19264070 0.76 TNK2 (0.63) TNK2IGF1RCYP3A4
SCHEMBL14536746 0.75 TNK2 (0.57) TNK2IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168968-B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI PHARMACEUTICALS LLC (US) 2017-08-23 EP disclosed
WO-2007061737-A2 FUSED BICYCLIC mTOR INHIBITORS OSI PHARMACEUTICALS, INC. (US) 2007-05-31 WO disclosed